Skip to main content
Impact of dupilumab prescribing on utilization of medical and surgical therapies for chronic rhinosinusitis with nasal polyps. International forum of allergy & rhinology Low, C. M., Wang, A. R., Yong, M., Nayak, J., Patel, Z., Hwang, P. H. 2024


Increased dupilumab utilization coincided with decreased ESS in patients with CRSwNP between 2019 and 2021. One potential confounder was the concurrent COVID-19 pandemic, which may have negatively impacted surgery utilization rates.

View details for DOI 10.1002/alr.23325

View details for PubMedID 38297486